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Abstract
NK cells resist engraftment of syngeneic and allogeneic bone marrow (BM) cells lacking
major histocompatibility (MHC) class I molecules, suggesting a critical role for donor MHC
class I molecules in preventing NK cell attack against donor hematopoietic stem and pro-
genitor cells (HSPCs), and their derivatives. However, using high-resolution in vivo imaging,
we demonstrated here that syngeneic MHC class I knockout (KO) donor HSPCs persist
with the same survival frequencies as wild-type donor HSPCs. In contrast, syngeneic MHC
class I KO differentiated hematopoietic cells and allogeneic MHC class I KO HSPCs were
rejected in a manner that was significantly inhibited by NK cell depletion. In vivo time-lapse
imaging demonstrated that mice receiving allogeneic MHC class I KO HSPCs showed a sig-
nificant increase in NK cell motility and proliferation as well as frequencies of NK cell contact
with and killing of HSPCs as compared to mice receiving wild-type HSPCs. The data indi-
cate that donor MHC class I molecules are required to prevent NK cell-mediated rejection of
syngeneic differentiated cells and allogeneic HSPCs, but not of syngeneic HSPCs.
Introduction
NK cells vigorously resist engraftment of syngeneic and allogeneic MHC class I KO BM cells
[1–3], indicating a critical role for donor MHC class I molecules in suppressing NK cell attack.
However, engraftment resistance may not simply reflect rejection of MHC class I KO HSPCs,
but rather of their derivatives. Therefore, it still remains unexplored whether prevention of NK
cell attack against donor HSPCs requires donor MHC class I molecules.
Our recent study suggests that tolerance against donor stem cells is achieved in a different
manner from that against differentiated cells [4]. High-resolution in vivomicroscopy (IVM)
enabled us to reveal persistence of allogeneic HSPCs in non-conditioned immune competent
recipient mice for an unexpectedly prolonged time (over 60 days), while differentiated cells
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were immediately rejected [4]. The data suggest that, compared to mature cells, HSPCs may
have a limited susceptibility to immune attack, similar to embryonic and germline stem cells
residing in immune privileged sites of the testis and the placenta [5–7].
We herein sought to determine whether MHC class I molecules of donor HSPCs [8] prevent
NK cell attack. Instead of engraftment assays, we utilized IVM [4,9,10] to track the fate of MHC
class I KO HSPCs and differentiated cells, respectively, following intravenous injection into alloge-
neic or syngeneic non-conditioned immune competent recipient mice. Allogeneic MHC class I
KO HSPCs and syngeneic MHC class I KO hematopoietic differentiated cells were both rejected in
a manner that was significantly inhibited by NK cell depletion. However, in contrast to the previ-
ous studies showing engraftment resistance of syngeneic MHC class I KO BM cells [1,2], we dem-
onstrated that syngeneic MHC class I KO donor HSPCs persist with the same survival frequencies
as wild-type donor HSPCs. Our data indicate that donor MHC class I molecules are required to
prevent NK cell attack against allogeneic HSPCs and syngeneic differentiated cells, but not synge-
neic HSPCs. Furthermore, a time-lapse live imaging approach enabled us to obtain a novel window
into the dynamic interaction of donor HSPCs with NK cells in vivo and in real-time.
Materials and Methods
Animals
C57BL/6J, Balb/cJ, B10.A mice (Jackson Laboratory, Bar Harbor, ME), B6 H2-Kb H2-Db Dou-
ble Knockout (B6.129P2-H2-Kbtm1 H2-Dbtm1 N12), BALB/c Rag2-/-mice, and BALB/c
Rag2-/-γc
-/-mice (Taconic, Hudson, NY) were housed in a specific pathogen-free environment.
The mice were anaesthetized with 2–3% isoflurane and burpenorphine. The mice were sacri-
ficed by CO2 inhalation and cervical dislocation. Studies were conducted with approval from
Institutional Review Boards and Animal Care and Use Committees at Columbia University.
Antibodies
FITC conjugated Lineage mAbs (B220, Mac1, GR-1, CD2, CD3a, CD8a, CD4, CD19 and
Ter119), APC-eFluor 780 conjugated ckit mAbs, and FITC conjugated Granzyme B mAbs
were purchased from eBioscience. PE conjugated CD49b mAbs, APC/Cy7 conjugated TCR-
βmAbs, BV510 conjugated CD3 mAbs, and APC conjugated NK1.1 mAbs were purchased
from Biolegend. BV605 conjugated Sca-I mAbs were purchased from BD Pharmingen.
Isolation and transplantation of HSPCs and differentiated cells
Bone marrow cells were isolated by crushing femurs, tibias, iliac bones, and vertebrae. After
centrifugation for 5 minutes at 1200 rpm, the cells were resuspended in 40% Percoll, and over-
laid on 80% Percoll in a 15 ml Falcon tube. Percoll gradient separation was performed by cen-
trifugation for 20 min at 2500 rpm at room temperature. Cells were collected from the
interphase, washed once, and stained with the antibodies listed above. cKit+Sca1+Lin- HSPCs,
or Lin+ differentiated cells were sorted using an Influx (Becton Dickinson), stained with 10 μM
DiD (Invitrogen) in PBS with 0.1% fetal bovine serum for 20 min at 37°C, and washed twice in
PBS with 0.1% fetal bovine serum. DiD-labeled HSPCs or Lin+ cells (30,000, or 500,000 cells
per recipient, respectively) were injected into the tail vein of recipient mice.
Transplantation of HSPCs or differentiated cells into mice depleted of
NK cells
We transplanted DiD-labeled B6 wild-type or MHC class I KO HSPCs (30,000 cells per
mouse) into non-irradiated allogeneic B10.A mice receiving anti-NK1.1 antibody treatment
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(0.2 mg/mouse) on day -5, -1, and 5. We transplanted DiD-labeled B6 wild-type or MHC class
I KO Lin+ cells (500,000 cells per mouse) into non-irradiated B6 mice receiving anti-NK1.1
antibody treatment (0.2 mg/mouse) on day -1, and 5.
Adoptive transfer of NK cells for the IVM study
18 hours after intraperitoneal injection of polyinosinic-polycytidylic acid (poly I:C) (100 μg/
mouse), NK cells were isolated from Balb/cJ mice using the NK cell isolation kit (Miltenyi, Ber-
gisch Gladbach, Germany). Subsequently, NK cells were stained with 10μMDiI in PBS with
0.1% fetal bovine serum for 20 min at 37°C, washed twice in PBS with 0.1% fetal bovine serum,
and were injected (0.5 x 106/mouse) into the tail veins of the mice.
IVM
The mice were anaesthetized with 2–3% isoflurane and burpenorphine. A small incision was
made in the scalp to expose the underlying skull bone, and then the mouse was placed on a cus-
tom-designed heated stage. The skull bone was kept intact. The temperature was maintained at
37°C by a heated pad placed under the mouse body. Imaging was performed using a Leica SP8
MP microscope (Leica Microsystems). Second harmonic microscopy was used to visualize the
bone and to identify the major anatomical landmarks such as the central vein and the coronal
suture. Bone rich in type-1 collagen was imaged by second harmonic generation using 870 nm
excitation and 430 nm detection. Using the crossing of the central vein and coronal sutures as
landmarks, we imaged identical areas of the skull (2540 μm (x) × 2570 μm (y) x 150 μm (z))
encompassing most of the parasagittal bone marrow cavities. The maximum imaging depth
reaches 100–150 μm, which corresponds to 1/2~2/3 of the skull BM [9]. DiD signal was excited
with a 633 nm laser and detected at 640–680 nm. DiI signal was excited with a 561 nm laser
and detected with a 580–620 nm. Images were processed and analyzed with Imaris (Bitplane,
version 5.7).
Flow cytometry following intracellular staining of gramzyme B
Cells obtained from bones were incubated for 4–5 hour with Monesin and Leukocyte Activa-
tion Cocktail (BD bioscience) at 37°C, fixed and permeabilized with Cytofix/Cytoperm kit (BD
Pharmingen). Subsequently, cells were stained with FITC-conjugated granzyme B mAbs
(eBioscience). Flow cytometry was performed using an LSRII (BD Biosciences) or FACS-
CANTO (BD Biosciences) cytometer followed by analysis using FlowJo software (Tree Star
Inc.).
Statistics
Statistical analyses were performed with GraphPad Prism software (version 6.0). Statistical sig-
nificance was determined by using 1-way analysis of variance (ANOVA) with Bonferroni post-
test analysis or 2-tailed t-test test. P values lower than 0.05 were considered to be significant.
All data are presented as mean ± SD.
Results
Transplantation of MHC class I KO HSPCs or differentiated cells
We sought to determine whether MHC class I molecules highly expressed by donor HSPCs [8]
(S1 Fig) prevent NK cell attack. Using IVM, we tracked the fate of MHC class I KO or wild-
type HSPCs following the intravenous injection into non-irradiated immune competent alloge-
neic or syngeneic recipients. cKit+Sca1+Lin- (KSL) HSPCs were isolated from B6 wild-type or
Differential Effect of NK Cells on HSC and Progeny
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H2-Kb H2-Db Double Knockout mice, labeled by lipophilic membrane dye, DiD, and injected
into the tail veins of non-irradiated BALB/c or B6 recipient mice (0.03 million cells/mouse).
On day 1 and 12, using IVM [4,9,10], we obtained 3D images of the skull BMs of the recipient
mice.
On day 1, the numbers of DiD-labeled B6 wild-type HSPCs and B6 MHC class I KO HSPCs
in identical regions of the skull BMs were comparable in BALB/c recipient mice (Fig 1A). This
indicates that the lack of MHC class I of donor HSPCs did not affect HSPC homing or rejection
in the circulation.
Importantly, on day 12, the lack of MHC class I on donor HSPCs led to a 50% reduction in
the numbers of donor HSPCs in allogeneic recipients (Fig 1B), but not a significant reduction
in syngeneic recipients (Fig 1C, S2 Fig, S1 Table). Regardless of titration of the numbers of
transplanted donor HSPCs, syngeneic MHC class I KO HSPCs survived with comparable
Fig 1. The lack of MHC class I expression by donor cells leads to rejection of allogeneic HSPCs and syngeneic differentiated cells, but not of
syngeneic HSPCs. (a, b) The numbers of B6 MHC class I KO and wild-type HSPCs in the identical regions (2540 μm (x) × 2570 μm (y) x 150 μm (z)) of the
skull BMs of non-irradiated BALB/c mice on day 1 (a: 3 recipients/group in an independent experiment), and day 12 (b: 8 vs 6 recipients/group pooled from
three independent experiments). (c) The numbers of B6 MHC class I KO and wild-type HSPCs in the skull BMs of non-irradiated B6 mice on day 12 (8 vs 6
recipients/group pooled from three independent experiments). (d) The numbers of B6 MHC class I KO and wild-type lineage+ differentiated cells in the
identical regions (2540 μm (x) × 2570 μm (y) x 150 μm (z)) of the skull BMs of B6 mice on day 7 (3 recipients/group in an independent experiment).
doi:10.1371/journal.pone.0141785.g001
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frequencies with syngeneic wild-type HSPCs (S3 Fig). Additionally, the IVM study following
intravenous injection of MHC class I KO differentiated (lineage+) cells into syngeneic B6 recip-
ients showed a significant rejection of syngeneic MHC class I KO differentiated cells (Fig 1D).
The data indicate that MHC class I expression by donor cells are required for preventing rejec-
tion of allogeneic HSPCs and syngeneic mature cells, but not of syngeneic HSPCs.
The survival frequencies of syngeneic MHC class I KO HSPCs were not significantly altered
by the simultaneous injection of syngeneic MHC class I KO BM cells that will activate NK cells
(S4 Fig). Therefore, the previously demonstrated engraftment resistance of syngeneic MHC
class I KO BM cells [1,2] may be attributed to the rejection of MHC class I KO donor differen-
tiated cells, but not of MHC class I KO stem cells.
The role of NK cells in the rejection of syngeneic MHC class I KO
differentiated cells and allogeneic MHC class I KO HSPCs
We next elucidated the role of NK cells in rejecting syngeneic MHC class I KO differentiated
cells and allogeneic MHC class I KO HSPCs. Flow cytometry analysis showed that granzyme-B
expression by BM NK cells is significantly up-regulated by transplantation of syngeneic MHC
class I KO differentiated cells and allogeneic MHC class I KO HSPCs, but not of syngeneic
MHC class I KO HSPCs (Fig 2A). Anti-NK1.1 antibody treatment significantly reversed the
decrease in the numbers of both syngeneic MHC class I KO differentiated cells (Fig 2B) and
allogeneic MHC class I KO HSPCs (Fig 2C). This indicates that NK cells play a critical role in
rejecting syngeneic MHC class I KO differentiated cells and allogeneic MHC class I KO
HSPCs.
To further determine whether NK cells are sufficient for rejecting allogeneic MHC class I
KO HSPCs, we compared the numbers of surviving B6 MHC class I KO HSPCs in non-irradi-
ated BALB/c T-, B-, NK-cell deficient Rag2-/-γc
-/-mice and BALB/c T-, B-cell deficient Rag2-/-
mice. The lack of MHC class I expression by donor HSPCs significantly reduced the numbers
of donor cells surviving in Rag2-/- mice, but not in Rag2-/-γc-/- mice (Fig 2D). Taken together
with the result of the study using anti-NK1.1 antibody treatment, the data indicate that MHC
class I of donor HSPCs plays a critical role in suppressing NK cell-mediated rejection in alloge-
neic recipients.
In vivo time-lapse imaging of NK cells and allo-HSPCs
We next utilized a time-lapse in vivo imaging approach to determine howMHC class I of
HSPCs influences the cellular dynamics of NK cells in live mice. NK cells were isolated from
BALB/c mice following intraperitoneal injection of polyinosinic:polycytidylic acid (poly I:C),
labeled by lipophilic membrane dye, DiI, and intravenously injected into non-irradiated
BALB/c mice (0.5 million cells/mouse). 24 hours after the injection of BALB/c NK cells, non-
irradiated BALB/c mice were intravenously injected with DiD-labeled B6 MHC class I KO or
wild-type HSPCs (0.08 million cells/mouse). The skull BMs of live recipient mice were imaged
by IVM 1 and 2 days after the injection of allogeneic HSPCs. The numbers of allogeneic MHC
class I KO HSPCs on day 2 decreased up to 50% compared to day 1, while the numbers of
wild-type HSPCs did not significantly change (Fig 3A). MHC class I KO HSPCs frequently
form clusters with NK cells, as compared to wild-type HSPCs (Fig 3B and 3C).
The NK cell numbers in the skull BMs increased over time more robustly in mice with allo-
geneic MHC class I KO HSPCs compared to those with wild-type HSPCs (Fig 3D).
The signal levels of the membrane dye, DiI of NK cells significantly decreased over time
in mice with MHC class I KO HSPCs, but not in mice with wild-type HSPCs (Fig 3E).
Because these NK cells were imaged at the comparable imaging depth (within 20 μm of the
Differential Effect of NK Cells on HSC and Progeny
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Fig 2. NK cells reject allogeneic MHC class I KO HSPCs and syngeneic MHC class I KO differentiated cells, but not syngeneic MHC class I KO
HSPCs. (a) Flow cytometry analysis of granzyme-B expression in NK cells in BALB/c mice transplanted with B6 MHC class I KO or wild-type HSPCs (left), in
B6 mice transplanted with B6 MHC class I KO or wild-type HSPCs (middle), and in B6 mice transplanted with B6 MHC class I KO or wild-type differentiated
cells (right). MFI: mean fluorescence intensity. 3 recipients/group were analyzed in an independent experiment. (b) The numbers of B6 MHC class I KO and
wild-type lineage+ cells in the identical regions (2540 μm (x) × 2570 μm (y) x 150 μm (z)) of the skull BMs of B6 mice receiving PBS or anti-NK1.1 antibody
Differential Effect of NK Cells on HSC and Progeny
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endosteal bone surface) (S5 Fig), the low level of DiI signals of NK cells suggests the dye dilu-
tion following rapid proliferation of NK cells in mice with MHC class I KO HSPCs. The data
indicate that NK cell proliferation was promoted in mice receiving allogeneic MHC class I
KO HSPCs.
The time-lapse movie showed that HSPCs are stationary compared to NK cells in all mouse
groups (S1 Video). MHC class I KO HSPCs more robustly activated the motility of NK cells
than wild-type HSPCs, which is indicated by the increase in the velocity and the decrease of the
arrest coefficient (the proportion of time in which NK cells do not move (velocity<2 μm/
min)) (Fig 3F and 3G, S2 and S3 Videos). Moreover, the velocity of NK cells with low DiI sig-
nals was higher than that of NK cells with high DiI signals (Fig 3H, S5 Fig, S2 Video). This sug-
gests that, following proliferation, NK cells became highly motile and acquired high immune
surveillance activity. Taken together, the data suggest that mice receiving allogeneic MHC class
I KO HSPCs showed a significant increase in NK cell motility and proliferation as well as fre-
quencies of NK cell contact with and killing of HSPCs as compared to mice receiving wild-type
HSPCs.
Although the previous imaging study revealed that NK cells in the tumor site repeat contact
with target cells prior to killing [11], NK cells in the BM formed stable contact with MHC class
I KO HSPCs and barely moved during the time-lapse movie recorded for more than 45 min-
utes (Fig 3I, S1 Video).
Discussion
The previous studies demonstrated NK cell-mediated engraftment resistance of both synge-
neic and allogeneic MHC class I KO BM cells [1–3]. But these studies did not rule out that
the possibility that only MHC class I KO donor differentiated cells, but not HSPCs, are
rejected. Our IVM study to track the fate of donor HSPCs and mature cells revealed persis-
tence of syngeneic MHC class I KO HSPCs, while NK cells rejected syngeneic MHC class I
KO differentiated cells and allogeneic MHC class I KO HSPCs. The data indicates that donor
MHC class I molecules are not required to prevent NK cell attack against syngeneic HSPCs,
but are against allogeneic HSPCs and syngeneic differentiated cells. The critical role for
donor MHC class I molecules in suppressing NK cell attack against allogeneic HSPCs is sup-
ported by other studies showing that NK cells only weakly resist long-term engraftment of
allogeneic BM cells [12], as well as engraftment following transplantation of allogeneic puri-
fied HSPCs [13].
NK cells may recognize the allogeneicity of MHC class I KO HSPCs through non-self recog-
nition by monocytes [14,15] that secret inflammatory cytokines, which may directly activate
NK cells [16] or induce up-regulation of NKG2D ligands by donor HSPCs [17]. Therefore, we
cannot exclude the possibility that MHC class I molecules of allogeneic donor HSPCs indirectly
suppress NK cells via monocytes or other cells. The failure of NK cells to reject syngeneic
MHC class I KO HSPCs may be due to enrichment of FoxP3+ regulatory T cells around donor
HSPCs that was demonstrated to allow allo-HSPC persistence in immune competent recipients
[4]. Our study using IVM established a novel experimental model that allows the investigation
of the dynamic interaction of immune cells with HSPCs in live mice. Future studies are war-
ranted to investigate the role of MHC class I expression in NK cell self-tolerance against endog-
enous HSPCs.
treatment. 3 recipients/group were analyzed in an independent experiment. (c) The numbers of MHC class I KO HSPCs persisting in non-irradiated B10.A
mice treated with PBS or ani-NK1.1 antibody on day 7. 3 recipients/group were analyzed in an independent experiment. (d) The numbers of MHC class I KO
HSPCs persisting in non-irradiated RAG2 -/- mice and RAG2 -/- Uc -/- mice on day 12. 3 recipients/group were analyzed in an independent experiment.
doi:10.1371/journal.pone.0141785.g002
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Fig 3. In vivo time-lapse imaging of NK cells and allo-HSPCs in the BM. (a) The numbers of B6 MHC class I KO or wild-type HSPCs in the skull BMs
(2540 μm (x) × 2570 μm (y) x 150 μm (z)) of BALB/c mice 1 and 2 days after the HSPC transplantation. 3 recipients/group were analyzed in an independent
experiment. (b) IVM showing direct contact of NK cells (blue) with MHC class I KO HSPCs (red). The scale bar indicates 100 μm. (c) The numbers of HSPCs
within 10 μm of NK cells in the identical regions (2540 μm (x) x 2570 μm (y) x 150 μm (z)) of the skull BMs. 3 recipients/group were analyzed in an
independent experiment. (d) The numbers of NK cells in the identical regions (800 μm (x) x 800 μm (y) x 150 μm (z)) of the skull BMs. (e) The intensity level
Differential Effect of NK Cells on HSC and Progeny
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Supporting Information
S1 Fig. MHC class I expression of cKit+Sca1+Lin- (KSL HSPCs) and spleen B220+ cells.
(PNG)
S2 Fig. IVM of B6 MHC class I KO HSPCs (right, red) and wild-type HSPCs (left, red) in
the skull BMs of non-irradiated BALB/c (above) or B6 (below) mice on day 12.
(PNG)
S3 Fig. Syngeneic MHC class I KO HSPCs survived with comparable frequencies with syn-
geneic wild-type HSPCs, regardless of titration of the numbers of transplanted donor
HSPCs. Following injection of 10,000 or 20,000 HSPCs per recipient, 3 recipients/group were
analyzed in an independent experiment. Following injection of 30,000 HSPCs per recipient, 8
or 6 recipients/group pooled from three independent experiments were analyzed.
(PNG)
S4 Fig. The numbers of DiD-labeled MHC class I KO HSPCs on day 12 were not signifi-
cantly altered by the co-injection of MHC class I KO BM cells. DiD-labeled B6 MHC class I
KO HPSCs (30,000/mouse) and non-labeled B6 MHC class I BM cells (5,000,000/mouse) were
simultaneously injected into the tail veins of syngeneic B6 recipients. The data were pooled
from at least two independent experiments.
(PNG)
S5 Fig. The depth of imaged NK cells for the study of dye dilution. (a) The depth of NK
cells from the endosteal bone surface (μm). (b) The depth of NK cells with high DiI signals
(RFU25) or low DiI signals (RFU<25). Red bar: average. The data were pooled from the
imaging of at least 3 recipients/group.
(PNG)
S1 Table. The numbers of B6 MHC class I KO and wild-type HSPCs in the identical regions
(2540 μm (x) × 2570 m (y) x 150 m (z)) of the skull BMs of BALB/c mice (above), and of
B6 mice on day 12 (below) on day 12. Three independent experiments per group were per-
formed.
(PNG)
S1 Video. Time-lapse movie of NK cells (green) interacting with allogeneic MHC class I
KO HSPCs (red).
(MOV)
S2 Video. Time-lapse movie of BM NK cells (green) in mice receiving allogeneic MHC class
I KO HSPCs. NK cells with high DiI signals (RFU25) are tracked by the red line, and NK
cells with low DiI signals (RFU<25) are tracked by the blue line.
(MOV)
S3 Video. Time-lapse movie of BM NK cells (green) in mice receiving allogeneic wild-type
HSPCs.
(MOV)
(Relative fluorescence unites (RFU)) of DiI of NK cells. (f) The velocity of NK cells. (g) The arrest coefficient (the proportion of time in which NK cells do not
move (velocity <2 μm)). (h) The correlation of the DiI signal levels with the velocity of NK cells. (i) The velocity and the displacement of NK cells located within
or more than 10 μm of HSPCs. The data were pooled from the imaging of at least 3 recipients/group (d-i).
doi:10.1371/journal.pone.0141785.g003
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